Aurevia Health Group

Transforming Healthcare and Extending Human Life.

Join us in revolutionizing healthcare delivery through innovative technology, strategic market positioning, and proven leadership in a $4.5 trillion industry.

Business, people and meeting presentation in office for project research, teamwork and budget discussion. Staff, communication and online of investment proposal, information and feedback in boardroom

Strategic Investment Opportunities

Series A: $10-15M Target

$10-15M
Series Seed Target
5-7 Years
IPO Pathway
2
Revenue Engines
Investment Thesis

The Aurevia Opportunity

Aurevia Health Group is redefining healthcare and wellness by merging two fast-growing sectors — scalable health services for America's aging population and high-margin longevity programs for the global elite.

Investment Summary

Operating as a single Delaware holding company, Aurevia's dual-engine model balances defensive recurring revenue (care) with premium cash-flow (wellness).

Capital Objective

$10-15 Million

Series Seed for acquisitions, flagship buildouts, staffing infrastructure, and licensing

Proven Dual-Engine Structure

Community healthcare + elite wellness for balanced growth

Massive Market Tailwinds

U.S. aging demographics + $6T global wellness market

High-Margin Scalability

Future IPO pathway within 5–7 years

Experienced Founding Team

Medical, operational, and visionary leadership

Market Snapshot

Metric Verified Source
U.S. 65+ Population → 71M by 2030 Census.gov / Cooper Center
National Health Expenditure → 20.3% GDP by 2033 CMS
U.S. Home Health Market ≈ $101B (2024) Fortune Business Insights
Global Wellness Economy ≈ $6.3T (2023) → $9T (2028) Global Wellness Institute
UHNW Population ≈ 426K (2023) Altrata
Request Private Investor Access

NDA Required • For Accredited Investors Only

Engine A

Aurevia Group — Health Services

Case Management & Home Care • Training Academy

~61.2M

U.S. 65+ Population (2024)

+3.1% YoY growth

Census.gov
20.3%

Health Expenditure of GDP

Projected by 2033

CMS
$176.3B

Home Healthcare by 2032

From $100.95B (2024)

Fortune Business
~4.5M

Medicaid HCBS Beneficiaries

Annually

KFF

Investor Interpretation

Revenue model balances predictability with growth

Medicaid contracts anchor predictable cash flow

Private-pay home care expands margins

Diversified payer mix reduces concentration risk

Staffing Academy Advantage

Internal talent pipeline creates competitive moat

Labor shortage limits growth sector-wide; an internal academy lowers cost-to-fill and boosts retention, creating a profitable internal supply engine.

CareAcademy trend data

Reduces recruitment costs

Improves staff retention rates

Ensures quality and consistency

Scalable talent pipeline

Investor Takeaway

Policy-supported demand + multi-payer revenue + academy flywheel = repeatable, capital-efficient U.S. rollout

Engine B

Aurevia Wellness & Longevity

Concierge Medicine • Flagship Centers • Longevity Retreats • Regenerative Programs

$9T

Global Wellness by 2028

From $6.3T (2023)

GWI
~426K

UHNW Population (2023)

North America leads

Altrata
$20.4B

Concierge Medicine Market

U.S.: ~$7.35B

Precedence
$42-52B

Regenerative Medicine

CAGR > 15%

Grand View
$954B

Wellness Tourism

CAGR 6–10%

Precedence

Market Interpretation

UHNW clients seek outcomes, privacy, and access; concierge memberships deliver high recurring revenue with minimal reimbursement risk.

High recurring membership revenue

No insurance reimbursement complexity

Premium pricing for retreats and therapies

Risk Note (Transparency)

Evidence rigor and regulatory oversight are essential in this space.

Aurevia Differentiators:

Physician governance and oversight

QA/IRB review protocols

Compliant research standards

Evidence-based program design

Investor Takeaway

High-margin membership base + flagship brand assets → scalable luxury ecosystem with global expansion potential

Synergy

Cross-Engine Synergy

HoldCo Advantage: Two engines working together create exponential value

Shared Funnel

Bi-directional client flow maximizes lifetime value

Medical care (Engine A) identifies clients for optimization programs (Engine B)

Wellness clients requiring follow-up route back into medical care

Shared Infrastructure

Centralized operations reduce SG&A per site

Centralized billing

Shared HR systems

Unified marketing

Single compliance platform

Integrated data analytics

Capital Logic

Balanced portfolio creates recession-resilient value

Engine A (Defensive): Steady cash flow from healthcare services

Engine B (Premium): Equity multiple and brand value from wellness

Community-driven foundation. Global elite expansion.

Together they create a balanced, recession-resilient portfolio that maximizes both stability and growth potential.

Growth Plan

Operational Roadmap

Strategic phased expansion from Georgia launch to national scale

I

Phase I

0–12 Months: Georgia Foundation

Acquire Georgia licenses

Launch case management services

Establish staffing academy

Build initial care network

II

Phase II

12–24 Months: Premium Expansion

Expand to Florida market

Launch West Palm Beach flagship center

Open Bahamas wellness retreat

Scale membership programs

III

Phase III

36+ Months: National Scale

Multi-state healthcare rollout

Additional flagship wellness centers

IPO readiness preparation

National brand recognition

Key Performance Indicators

Engine A Metrics

  • Care-start timing
  • Patient retention rates
  • Payer mix diversity
  • Days sales outstanding (DSO)

Engine B Metrics

  • Membership ARPU
  • Service utilization mix
  • Gross margin per member
  • Retention and LTV

System Metrics

  • EBITDA growth trajectory
  • SG&A ratio decline
  • Expansion cost per site
  • Cross-engine conversion
View Detailed Roadmap (PDF)
Leadership

Team & Governance

World-class founding team with proven medical, operational, and strategic expertise

James Jim Hooker

James "Jim" Hooker

Co-Founder & Chief Executive Officer

15+ years in multi-site regenerative operations and governance; leads strategy and investor relations with expertise in building scalable healthcare platforms.

Ralph E. Cadet

Ralph E. Cadet, MBA, MD-Candidate

Co-Founder & Chief Medical Officer

Clinical strategist specializing in regenerative medicine and longevity science; builds evidence-based programs and QA systems ensuring measurable outcomes.

Robert C. Lewis

Robert C. Lewis

Co-Founder & Chief Operating Officer

Operations and real estate development leader with hospitality and wellness expertise; drives buildout execution with precision and quality standards.

Ricardo Rosselló Nevares, PhD

Ricardo "Ricky" Rosselló Nevares, PhD

Co-Founder & Chief Visionary Officer

Directs scientific roadmap, R&D partnerships, and regulatory innovation; bridges academic and commercial pathways for cellular and biologic technologies.

Governance Structure

Corporate Structure

Delaware C-Corp HoldCo with licensed subsidiaries in GA & FL

Board Committees

  • Clinical Oversight
  • Audit Committee
  • Compensation Committee

Reporting & Oversight

  • Quarterly reporting
  • Independent audit oversight
  • Investor transparency

Policies & Compliance

  • Ethics Charter
  • Data Privacy Standards
  • Risk Management Framework
  • Compliance Manual

Learn more about our founding team and vision

Visit About Page
Risk Management

Compliance & Risk

Transparent regulatory framework and comprehensive risk mitigation strategies

Regulatory Framework

Comprehensive compliance across all operations

HCBS Medicaid Alignment

Full compliance with Home and Community-Based Services standards

HIPAA & Data Privacy

Protected health information security and privacy protocols

CMS Standards

Medicare and Medicaid reimbursement compliance

CLIA & IRB Protocols

Clinical lab standards and research review for regenerative programs

Clinical QA Systems

Quality assurance and incident reporting standards

Risk Mitigation

Proactive strategies protecting investor capital

Diversified Payer Mix

Balanced revenue across Medicare FFS, Medicare Advantage, Medicaid waivers, and private-pay reduces single-payer concentration risk.

Scalable Academy Pipeline

Internal staffing academy ensures consistent talent supply, mitigating workforce shortage impacts on growth.

Legal Counsel & Fiduciary Safeguards

Expert legal oversight and fiduciary structures protect investor interests and ensure transparent governance.

Dual-Engine Resilience

Healthcare engine provides defensive cash flow during economic downturns while wellness engine captures premium upside in growth periods.

Investor Updates

Milestones & News

Stay informed about our progress, strategic developments, and key milestones as we build the future of integrated healthcare.

21
Oct 2025
Milestone Achieved

Platform Development Reaches Beta Phase

Our unified healthcare coordination platform has successfully completed alpha testing and entered beta phase with 50+ pilot users across our home health network. Initial results show a 35% improvement in care coordination efficiency and 28% reduction in administrative overhead.

35%
Efficiency Gain
50+
Beta Users
Next Steps: Full platform launch scheduled for Q1 2026, with integration of telehealth and chronic care management modules.
15
Oct 2025
Strategic Update

Acquisition Target Identified for Q1 2026

We have identified and initiated preliminary discussions with a regional home health agency serving 3 counties with approximately 250 active patients. This acquisition aligns with our Phase I expansion strategy and will strengthen our market presence in Delaware.

  • Due diligence phase initiated with financial and operational audits
  • Target shows strong EBITDA margins (18%) and complementary service offerings
  • Integration plan being developed to maintain continuity of care
Timeline: LOI expected by November 2025, closing targeted for January 2026.
03
Oct 2025
Operations

Home Health Division Reaches 100+ Active Patients

Our home health services division has successfully crossed the 100-patient milestone, ahead of our Q4 target. Patient satisfaction scores average 4.7/5.0, and we've secured contracts with 3 additional Medicare Advantage plans.

100+
Active Patients
4.7/5
Satisfaction
15
Care Providers
Revenue Impact: On track to exceed Q4 revenue projections by 15%.
28
Sep 2025
Compliance

HIPAA and State Licensing Compliance Certified

We have successfully completed our HIPAA compliance certification and received full state licensing approval for home health operations in Delaware. Our technology platform passed security audits with zero critical findings.

  • HIPAA compliance certification obtained
  • Delaware state home health license approved
  • Medicare provider enrollment completed
15
Sep 2025
Team Growth

Key Leadership Hires Strengthen Clinical Operations

We've welcomed experienced healthcare leaders to our team, including a Chief Clinical Officer with 20+ years in home health management and a Director of Quality Assurance with extensive Medicare compliance experience.

Team Size: Now at 25 full-time employees including clinical, operations, and technology staff.
View Full Archive
Your Voice Matters

Investor Feedback & Insights

We value your perspective. Share your thoughts, questions, or strategic insights to help shape the future of Aurevia Health Group.

We're Listening

Your feedback directly influences our strategic decisions. Whether you have questions about our progress, suggestions for improvement, or insights on market opportunities, we want to hear from you.

We review all feedback within 48 hours

Direct Email

[email protected]

Schedule Call

Book a Meeting

Investor Portal

Request Access

Confidentiality & Privacy

All feedback and communications are treated as confidential and subject to existing investor agreements. Your insights help us improve transparency and strengthen our strategic approach.

Get Started

Contact Investor Relations

Secure access to confidential materials for qualified accredited investors

Email

[email protected]

Phone

+1 (302) 406-8388

Address

8 The Green #14608
Dover, DE 19901

Access Protocol

1

Complete NDA

Download and sign the Non-Disclosure Agreement

Download NDA
2

Schedule Briefing

Book an investor briefing call with our IR team

Schedule Call
3

Receive Materials

Access private deck and financial model

Secure Portal

Office Hours

Monday – Friday: 9:00 AM – 6:00 PM EST

Request Investor Access

NDA Required • For Accredited Investors Only

View Market Opportunity Meet the Team General Contact